AM
Ananta Manohar Meduri Chakravartula
About Ananta Manohar Meduri Chakravartula
Data last updated:
Ananta Manohar Meduri Chakravartula is a Nominee Director at Dme Development Limited (since 2022). The company operates in Infrastructure and Utilities. Dme Development Limited reported revenue of ₹2,211 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dme Development Limited U45202DL2020GOI368878 | Nominee Director | 23 Dec 2022 | 2020 | ₹2,211 Cr (FY 2025) | Active |
Board colleagues of Ananta Manohar Meduri Chakravartula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alok Deepankar | 07317490 | Dme Development Limited | Nominee Director |
| Neti Ravi Vijay Venkat Murali Krishna Rajendrakumar | 09494456 | Dme Development Limited | Nominee Director |
| Prachi Mittal | 07495386 | Dme Development Limited | Company Secretary |
| Rajesh Ranjan | 10094828 | Dme Development Limited | Director |
| Rupesh Kumar Srivastava | Dme Development Limited | Ceo | |
| Sudha Damodar | 07755170 | Dme Development Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ananta Manohar Meduri Chakravartula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ananta Manohar Meduri Chakravartula
Ananta Manohar Meduri Chakravartula currently holds 1 directorship: Dme Development Limited (Nominee Director, since 23 Dec 2022, revenue ₹2,211 Cr (FY 2025)).
Ananta Manohar Meduri Chakravartula was first appointed on 23 Dec 2022 as Nominee Director at Dme Development Limited.
The current boards of Ananta Manohar Meduri Chakravartula's companies include Alok Deepankar (Dme Development Limited), Neti Ravi Vijay Venkat Murali Krishna Rajendrakumar (Dme Development Limited), Prachi Mittal (Dme Development Limited), Rajesh Ranjan (Dme Development Limited), Rupesh Kumar Srivastava (Dme Development Limited), Sudha Damodar (Dme Development Limited).